Table 1

Clinical and laboratory findings

Patient no.123456789101112131415
Age, y/sex53/M59/M35/M51/M54/F41/F48/F39/M57/M23/M53/F30/M45/F49/M36/F
DiagnosisFSFSFSFSFSFSFSFSFSFSFS/GBSBBE/GBSBBE/GBSAOAO
Antecedent illnessURTIURTIURTIURTIURTIURTIURTIURTIURTIURTIURTIURTIURTI
Ophthalmoplegia+++++++++++++++
Ataxia+++++++++++++
Areflexia or hyporeflexia+++++++++++++++
Facial weakness+++
Bulbar weakness+++++
Respiratory support+++
Limb weakness+++
Sensory abnormalitiesNumbness of fingersParaesthesia and loss of fine touch upper and lower limbsParaesthesia and loss of fine touch upper and lower limbsParaesthesia and loss of fine touch handsParaesthesia and loss of fine touch upper and lower limbsDecreased pain sensation upper limbParaesthesia and loss of fine touch upper and lower limbs
Disturbed consciousnessConfusion, drowsinessComa
CSF cells (/μl)/protein (g/dl)1/0.361/0.400/0.260/0.751/0.602/0.351/0.20 (RBC 10/μl)3/0.382/0.41 (RBC 20/μl)Not done2/0.31; 4/0.687/0.50 (RBC 88/μl)54/0.270/0.895/0.50 (RBC 2585/μl)
IgG anti-GQ1b antibody+++++++++Not tested++++
  • AO, acute ophthalmoparesis; BBE/GBS, Bickerstaff brainstem encephalitis overlapping with Guillain–Barré syndrome; CSF, cerebrospinal fluid; FS, Fisher syndrome; FS/GBS, FS overlapping with Guillain–Barré syndrome; RBC, red blood cell; URTI, upper respiratory tract infection.